Back

The cystatin c–to–creatinine eGFR ratio and subclinical cardiac structure and function in a population-based cohort

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiac structure, function, and symptoms in cardiometabolic and systemic disease Systolic and Diastolic Function ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Haris Zilic

Skane University Hospital, Malmo (Sweden)

7 More presentations in this session

Presentation thumbnail
Fibrosis-4 (FIB-4) score is associated with early diastolic dysfunction in metabolic dysfunction-associated steatotic liver disease (MASLD)
Professor S. Ryu (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Associations between cardiac biomarkers and cardiac structure and function in patients with psoriasis
Doctor J. Borchsenius (Hellerup, DK)
Abstract Slides Video
Presentation thumbnail
Cardiovascular-kidney-metabolic (CKM) syndrome stage is associated with impaired cardiac structure/function and increased symptom burden in patients with MASLD
Mr A. Reimer Jensen (Gentofte, DK)
Abstract Slides Video
Presentation thumbnail
Prevalence of cardiac dysfunction and symptoms in long COVID
Ms Z. Hassan Juma (DK)
Abstract Slides Video
Presentation thumbnail
Global myocardial performance and long-term mortality after TAVI: prognostic value of the TEI index
Doctor N. Clodi (Salzburg, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac structure, function, and symptoms in cardiometabolic and systemic disease

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Correlation between renal function level and ventricular remodeling, and mechanistic study of slc10a6-mediated ventricular remodeling after chronic kidney disease
29 August 2025
thumbnail
Congress Session
Population-based studies on echocardiography: from establishing normal values to predicting outcomes
26 August 2023
thumbnail
Congress Presentation
Integration of echocardiographic and biomarker parameters for functional stratification and risk prediction in HFpEF patients
13 December 2025
thumbnail
Congress Presentation
The value of Cystatin C in the diagnosis of cardiorenal syndrome type 1
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources